# HilleVax (stock symbol: HLVX) Logo in transparent PNG format

## HilleVax Logo large

### HilleVax Logo large Download PNG (46.97 KB)

![HilleVax Logo large Download PNG (46.97 KB)](/img/orig/HLVX_BIG-81f68eb8.png)

## HilleVax Logo icon format

### HilleVax Logo icon format Download PNG (39.36 KB)

![HilleVax Logo icon format Download PNG (39.36 KB)](/img/orig/HLVX-5d410b50.png)

## HilleVax Logo large for dark backgrounds

### HilleVax Logo large for dark backgrounds Download PNG (37.65 KB)

![HilleVax Logo large for dark backgrounds Download PNG (37.65 KB)](/img/orig/HLVX_BIG.D-0c0ecee5.png)

## About HilleVax

HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.

1. Website domain: hillevax.com
2. Employees: 15
3. Marketcap: $0.54 Billion USD


## Categories
- [x] ðŸ‡ºðŸ‡¸ United States
- [x] ðŸ’Š Pharmaceuticals
- [x] ðŸ§¬ Biotech
